SL
ENTX icon

Siren LLC’s Entera Bio ENTX Stock Holding History

Siren LLC’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
+736,457
New +$921K 0.03% 110

Other funds holding ENTX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Siren LLC's ENTX Position: Q2 2026 in Review

Siren LLC opened a new position in Entera Bio (ENTX) in Q2 2026: 736,457 shares worth $1.3M. The stake represents 0.03% of the portfolio and ranks #110 among its holdings.

15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Siren LLC held 736,457 shares of Entera Bio worth $1.3M as of Q2 2026.
  • Entera Bio was a new Siren LLC position in Q2 2026.
  • Entera Bio made up 0.03% of Siren LLC's portfolio in Q2 2026, its #110 holding.
  • 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.